About HIV Clinical Trials
HIV Clinical Trials is devoted exclusively to keeping you in touch with the latest developments and techniques in HIV/AIDS therapeutics. This is where you'll gain a more complete picture of worldwide developments.
"HIV Clinical Trials is a great outlet for our work. The review and editorial process has been fast and fair...could not ask for anything more." - Seth Kalichman, PhD
HIV Clinical Trials coverage includes:
- the results of therapeutic, diagnostic, or preventive clinical trials, reports of clinical research, and meta- analysis
- pilot studies
- methodological papers
- review articles
- quality of life and pharmacoeconomic evaluations
- letters to the editor
- abstracts of conferences
Subscriptions include online access to the current issue and a full-text archive of all previous issues
Articles over 12 months old and all abstracts regardless of publication date are open access. Subscribers also have access to current issues and live reference links via the CrossRef system.
Check our new lower subscription rates at SUBSCRIBE.
Build your knowledge base with authoritative, practical information
Editors-in-Chief, Judith A. Aberg MD, Alain Lafeuillade MD, and Caroline A. Sabin PhD, work closely with a world-renowned Board of Editors to ensure that HIV Clinical Trials delivers the insightful information on HIV/AIDS therapeutics you need.
HIV Clinical Trials is indexed in Index Medicus and MEDLINE; EMBASE, the Excerpta Medica database and Elsevier BIOBASE; Science Index® Expanded®, ISI Alerting Services® and Current Contents®/Clinical Medicine®.
Thinking of writing for HIV Clinical Trials?
We combine a thorough peer review process with faster time to publication; typically about 4 months from receipt of a manuscript to publication.
Our commitment is to get your information to the field at the earliest date that can be responsibly achieved. For more information on writing for HIV Clinical Trials see our instructions for authors.